<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04779528</url>
  </required_header>
  <id_info>
    <org_study_id>442/2021/67</org_study_id>
    <nct_id>NCT04779528</nct_id>
  </id_info>
  <brief_title>Awake Nasal Fiber-optic Intubation of Severely Obese Patients in Lateral Position</brief_title>
  <official_title>Awake Nasal Fiber-optic Intubation of Severely Obese Patients in Lateral Position: a Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jordan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Airway management in severely obese patients remains a challenging issue for anesthetists and&#xD;
      may lead to life-threatening situations. Awake Fiber-Optic Bronchoscopy Intubation (FOBI)&#xD;
      technique is considered as the gold standard when a difficult airway is anticipated to secure&#xD;
      the airway and to facilitate the surgery. FOBI is usually done in supine position, while (in&#xD;
      conscious patients) lateral position is the most recommended position to keep the upper&#xD;
      airway patent. This prospective clinical trial study will test whether awake FOBI in Lateral&#xD;
      position will provide a safe profile or a significant advantage over FOBI in supine position,&#xD;
      in morbidly obese patients undergoing elective bariatric surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Airway management in severely obese patients remains a challenging issue for anesthetists and&#xD;
      may lead to life-threatening situations. Awake Fiber-Optic Bronchoscopy Intubation (FOBI)&#xD;
      technique is considered as the gold standard when a difficult airway is anticipated to secure&#xD;
      the airway and to facilitate the surgery. FOBI is usually done in supine position, while (in&#xD;
      conscious patients) lateral position is the most recommended position to keep the upper&#xD;
      airway patent.&#xD;
&#xD;
      This prospective clinical trial study will test whether awake FOBI in Lateral position will&#xD;
      provide a safe profile or a significant advantage over FOBI in supine position, in morbidly&#xD;
      obese patients undergoing elective bariatric surgery. The main outcome is success rate and&#xD;
      duration of the procedure. Secondary outcomes are oxygenation maintenance, hemodynamic&#xD;
      stability, airway complication, sedation score, and postoperative airway morbidity in 6 hours&#xD;
      after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of fiberoptic intubation.</measure>
    <time_frame>5 minutes</time_frame>
    <description>The investigators will compare between the supine and lateral positions in terms of the duration needed for the insertion of an endotracheal tube via fiberoptic intubation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications during airway manipulation.</measure>
    <time_frame>5 minutes</time_frame>
    <description>The investigators will document the occurrence of adverse events during fiberoptic intubation, and compare these complications between the two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia</condition>
  <condition>Intubation;Difficult</condition>
  <condition>Intubation; Difficult or Failed</condition>
  <condition>Anesthesia Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Group S</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo fiberoptic intubation in supine position.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo fiberoptic intubation in lateral position.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fiberoptic intubation in supine position.</intervention_name>
    <description>Patients will be placed in supine position after the establishment of full vital signs monitoring and the insertion of an intravenous line.&#xD;
Under sedation via intravenous infusion of remifentanil plus topical anesthesia with 10 ml of Lidocaine 1% via a 3.7mm bronchoscope. After applying a standard monitoring and preparation of the nose by decongestant and local anesthesia. A loaded flexible scope (by an endotracheal tube ETT) will be introduced through the nostril to reach the carina, then the ETT will be pushed over the scope 3cm above the carina.</description>
    <arm_group_label>Group S</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fiberoptic intubation in lateral position.</intervention_name>
    <description>Patients will be placed in lateral position after the establishment of full vital signs monitoring and the insertion of an intravenous line.&#xD;
Under sedation via intravenous infusion of remifentanil plus topical anesthesia with 10 ml of Lidocaine 1% via a 3.7mm bronchoscope. After applying a standard monitoring and preparation of the nose by decongestant and local anesthesia. A loaded flexible scope (by an endotracheal tube ETT) will be introduced through the nostril to reach the carina, then the ETT will be pushed over the scope 3cm above the carina.</description>
    <arm_group_label>Group L</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status classification two and three.&#xD;
&#xD;
          -  Patients scheduled for elective bariatric surgeries under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of fiberoptic intubation.&#xD;
&#xD;
          -  Allergy to local anesthetics.&#xD;
&#xD;
          -  Coagulopathy.&#xD;
&#xD;
          -  Raised intracranial or intraocular pressure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Omar A Ababneh</last_name>
    <phone>00962 5353000</phone>
    <phone_ext>2389</phone_ext>
    <email>omar.ababneh@ju.edu.jo</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jordan University Hospital</name>
      <address>
        <city>Amman</city>
        <zip>11942</zip>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Secrerary of Anesthesia and Intensive Care Department</last_name>
      <phone>00962 5353000</phone>
      <phone_ext>2383</phone_ext>
      <email>Anaesthesia@ju.edu.jo</email>
    </contact>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 27, 2021</study_first_submitted>
  <study_first_submitted_qc>February 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jordan</investigator_affiliation>
    <investigator_full_name>omar ahmad ababneh</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Intubation</keyword>
  <keyword>obesity</keyword>
  <keyword>fiberoptic</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

